Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with st-segment elevation myocardial infarction undergoing primary percutaneous intervention

American Journal of Cardiology

Volumn 110, Issue 12, 2012, Pages 1756-1763

  Lyngbæk, Stig ^a   Marott, Jacob L ^b   Moller, Daniél V ^c   Christiansen, Michael ^c   Iversen, Kasper K ^d   Clemmensen, Peter M ^d   Eugen Olsen, Jesper ^b   Jeppesen, Jorgen L ^b   Hansen, Peter R ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Mental Health Services CPH   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; DEATH; FATALITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; RECURRENCE; SURVIVAL ANALYSIS;

EID: 84870296762     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.008     Document Type: Article

References (23)

1. J. Eugen-Olsen, O. Andersen, A. Linneberg, S. Ladelund, T.W. Hansen, A. Langkilde, J. Petersen, T. Pielak, L.N. Moller, J. Jeppesen, S. Lyngbaek, M. Fenger, M.H. Olsen, P.R. Hildebrandt, K. Borch-Johnsen, T. Jorgensen, S.B. Haugaard Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population J Intern Med 268 2010 296 308
2. M. Thuno, B. Macho, J. Eugen-Olsen suPAR: the molecular crystal ball Dis Markers 27 2009 157 172
3. K.K. Iversen, A.S. Teisner, B. Teisner, A. Kliem, P. Thanning, P. Grande, P. Clemmensen Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction Am J Cardiol 101 2008 1389 1394
4. J. Jeppesen, T.W. Hansen, M.H. Olsen, S. Rasmussen, H. Ibsen, C. Torp-Pedersen, P.R. Hildebrandt, S. Madsbad C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study Eur J Cardiovasc Prev Rehabil 15 2008 594 598
5. O. Andersen, J. Eugen-Olsen, K. Kofoed, J. Iversen, S.B. Haugaard Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy J Med Virol 80 2008 209 216
6. D.Y. Lin, L.J. Wei, Z. Ying Checking the Cox model with cumulative sums of martingale-based residuals Biometrika 80 1993 557 572
7. S. Lyngbaek, J.L. Marott, T. Sehestedt, T.W. Hansen, M.H. Olsen, O. Andersen, A. Linneberg, S.B. Haugaard, J. Eugen-Olsen, P.R. Hansen, J. Jeppesen Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham risk score Int J Cardiol 2012 Aug 18 Epub
8. H. Uno, T. Cai, M.J. Pencina, R.B. D'Agostino, L.J. Wei On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data Stat Med 30 2011 1105 1117
9. S. May, D.W. Hosmer A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model Lifetime Data Anal 4 1998 109 120
10. M.J. Pencina, R.B. D'Agostino Sr, E.W. Steyerberg Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers Stat Med 30 2011 11 21
11. V. Viallon, S. Ragusa, F. Clavel-Chapelon, J. Bénichou How to evaluate the calibration of a disease risk prediction tool Stat Med 28 2009 901 916
12. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr, R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
13. L.E. Chambless, C.P. Cummiskey, G. Cui Several methods to assess improvement in risk prediction models: extension to survival analysis Stat Med 30 2011 22 38
14. A. Kjellman, O. Akre, O. Gustafsson, G. Hoyer-Hansen, H. Lilja, U. Norming, T. Piironen, M. Törnblom Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening J Intern Med 269 2011 299 305
15. M. Persson, G. Engström, H. Björkbacka, B. Hedblad Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD: results from the Malmö Diet and Cancer Study Atherosclerosis 220 2012 502 505
16. R. Huttunen, J. Syrjänen, R. Vuento, M. Hurme, H. Huhtala, J. Laine, T. Pessi, J. Aittoniemi Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study J Intern Med 270 2011 32 40
17. A. Koch, S. Voigt, C. Kruschinski, E. Sanson, H. Dückers, A. Horn, E. Yagmur, H. Zimmermann, C. Trautwein, F. Tacke Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients Crit Care 15 2011 R63
18. C.E. de Bock, Y. Wang Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer Med Res Rev 24 2004 13 39
19. S. Lyngbaek, T. Sehestedt, J.L. Marott, T.W. Hansen, M.H. Olsen, O. Andersen, A. Linneberg, S. Madsbad, S.B. Haugaard, J. Eugen-Olsen, J. Jeppesen CRP and suPAR are differently related to anthropometry and subclinical organ damage Int J Cardiol 2012 Mar 27 Epub
20. B. Fuhrman The urokinase system in the pathogenesis of atherosclerosis Atherosclerosis 222 2012 8 14
21. T. Sehestedt, S. Lyngbaek, J. Eugen-Olsen, J. Jeppesen, O. Andersen, T.W. Hansen, A. Linneberg, T. Jorgensen, S.B. Haugaard, M.H. Olsen Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events Atherosclerosis 216 2011 237 243
22. P. Ortolani, A. Marzocchi, C. Marrozzini, T. Palmerini, F. Saia, N. Taglieri, F. Baldazzi, S. Silenzi, M.L. Bacchi-Reggiani, P. Guastaroba, R. Grilli, A. Branzi Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention Eur Heart J 29 2008 1241 1249
23. M. Madsen, M. Davidsen, S. Rasmussen, S.Z. Abildstrom, M. Osler The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish Monica registry J Clin Epidemiol 56 2003 124 130